# Iontophoresis in Psoriasis

> **NCT03979664** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Psoriasis
- Psoriasis Vulgaris
- Skin Diseases

## Interventions

- **DEVICE:** Activapatch intellidose 2.5 using active Iontophoresis
- **DEVICE:** Activapatch intellidose 2.5 using inactive Iontophoresis
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03979664
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** FDA did not provide approval of the use of the drug for the study
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03979664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03979664, "Iontophoresis in Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03979664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*